Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study

This study aimed to investigate the cost-effectiveness of preimplantation genetic diagnosis (PGD) for the reproductive choices of patients with heritable retinoblastoma. The study modelled the costs of three cycles of in-vitro fertilization (IVF) and PGD across all uptake rates of PGD, number of chi...

Full description

Bibliographic Details
Main Authors: D. Schofield, M.J.B. Zeppel, S. Staffieri, R.N. Shrestha, D. Jelovic, E. Lee, R.V. Jamieson
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Reproductive Biomedicine & Society Online
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405661820300095